Shareholders Equity and Capital Stock (Details 6) - USD ($) $ / shares in Units, $ in Thousands |
9 Months Ended | ||
|---|---|---|---|
Sep. 30, 2024 |
Mar. 31, 2024 |
Dec. 31, 2023 |
|
| Exercise price | $ 1.50 | $ 1.50 | $ 1.46 |
| Number of warrants | 39,041,000 | 39,041,000 | 55,417,500 |
| Warrants | |||
| Exercise price | $ 1.50 | ||
| Number of warrants | 39,041,000 | ||
| Remaining contractual life (years) | 1 year 4 months 24 days | ||
| Aggregate Intrinsic Value | $ 0 | ||
| Exercise price $1.50 | |||
| Exercise price | $ 1.50 | ||
| Number of warrants | 39,041,000 | ||
| Remaining contractual life (years) | 1 year 4 months 24 days | ||
| Aggregate Intrinsic Value | $ 0 | ||
| Expiry | Feb. 21, 2026 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
| X | ||||||||||
- Definition Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|